Francesco Zaja

13PUBLICATIONS
69CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyRheumatology and arthritisHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 04, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0.

|Apr 02, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL Study.

Francesca Maria Quaglia, Lara Mannelli, Luca Pagliaro

|Jan 30, 2024
Unmet needs in relapsed/refractory mantle cell lymphoma after failure of covalent Bruton's tyrosine kinase inhibitors: An Italian scenario.

Antonio Pinto, Marco Ladetto, Maurizio Martelli

|Jan 24, 2024
An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.

Andrea Marra, Alessia Santi, Alessandra Pucciarini

|Jan 17, 2024
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.

Maria Gabriella Mazzucconi, Francesco Rodeghiero, Giuseppe Avvisati

|Jan 08, 2024
Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.

Marco Herling, Claire Dearden, Francesco Zaja

Pageof 3

Frequent Collaborators

4 joint publications

Pier Luigi Zinzani

3 joint publications

Andrea Patriarca

3 joint publications

Francesca Palandri

2 joint publications

Giuseppe Auteri